Public-registry site landscape for NCT02929862, a Cancer study sponsored by Lycera Corp.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02929862 (registry record) |
| Sponsor | Lycera Corp. |
| Condition(s) | Cancer |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 20 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT02929862 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →